[HTML][HTML] Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study
K Shiozawa, M Watanabe, Y Kikuchi… - World Journal of …, 2012 - ncbi.nlm.nih.gov
AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study
K Shiozawa, M Watanabe, Y Kikuchi, T Kudo… - World Journal of …, 2012 - hero.epa.gov
AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
[PDF][PDF] Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
K Shiozawa, M Watanabe, Y Kikuchi, T Kudo… - World J …, 2012 - researchgate.net
AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study.
K Shiozawa, M Watanabe, Y Kikuchi… - World Journal of …, 2012 - europepmc.org
Aim To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: a pilot study
K Shiozawa, M Watanabe, Y Kikuchi… - World journal of …, 2012 - pubmed.ncbi.nlm.nih.gov
Aim To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
[HTML][HTML] Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
K Shiozawa, M Watanabe, Y Kikuchi, T Kudo… - World Journal of …, 2012 - wjgnet.com
AIM: To determine the usefulness of arrival time parametric imaging (AtPI) using contrast-
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
enhanced ultrasonography (CEUS) with Sonazoid in evaluating early response to sorafenib …
[引用][C] Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
K Shiozawa - World Journal of Gastroenterology, 2012 - cir.nii.ac.jp
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A
pilot study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
pilot study | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Evaluation of sorafenib for hepatocellular carcinoma by contrast-enhanced ultrasonography: A pilot study
K Shiozawa, M Watanabe, Y Kikuchi, T Kudo… - World Journal of …, 2012 - wjgnet.com
Figure 2 Clinical example of good responder patient. A 74-year-old man with a history of
hepatitis C virus cirrhosis underwent transcatheter arterial chemoembolization (TACE) for …
hepatitis C virus cirrhosis underwent transcatheter arterial chemoembolization (TACE) for …